NASDAQ:MLND - Millendo Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$14.69 +0.25 (+1.73 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$14.69
Today's Range$14.10 - $14.84
52-Week Range$6.77 - $15.15
Volume25,014 shs
Average Volume26,841 shs
Market Capitalization$189.65 million
P/E Ratio-0.74
Dividend YieldN/A
Beta3.3

Analyst Ratings

Millendo Therapeutics (NASDAQ:MLND) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Millendo Therapeutics in the last 12 months. Their average twelve-month price target is $25.00, suggesting that the stock has a possible upside of 70.18%. The high price target for MLND is $29.00 and the low price target for MLND is $22.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $25.00$26.50$24.00N/A
Price Target Upside: 70.18% upside246.41% upsideN/AN/A

Millendo Therapeutics (NASDAQ:MLND) Consensus Price Target History

Price Target History for Millendo Therapeutics (NASDAQ:MLND)

Millendo Therapeutics (NASDAQ:MLND) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/13/2019Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$22.00HighView Rating Details
1/4/2019LADENBURG THALM/SH SHInitiated CoverageBuy ➝ Buy$29.00N/AView Rating Details
12/13/2018Leerink SwannInitiated CoverageOutperform ➝ Outperform$24.00N/AView Rating Details
(Data available from 3/23/2017 forward)
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: What is the NASDAQ?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel